New Phesi global analysis shows breast cancer was the most extensively studied disease area...
Phesi Inc., a data-driven provider of AI-powered clinical development analytics and solutions, has released the...
AES Clean Technology Accelerates Cleanroom Capabilities with $14.2 million Investment
AES Clean Technology, a leading provider of high-performance cleanroom facilities within the pharmaceutical and bio-pharmaceutical...
Cabenuva HIV Drug From GlaxoSmithKline Gets FDA Approval
Last year, GlaxoSmithKline’s ViiV Healthcare’s feat of getting a long-awaited approval of HIV treatment by...
In GSK Patent Settlement, Gilead To Pay $1.25B On Biktarvy
It doesn’t come as a shock when we hear that GlaxoSmithKline and Gilead Sciences are...
Biogen Exercises Option to Participate in the Development and Commercialization of a Late-Stage Bispecific...
Biogen Inc. announced that it exercised its option to participate in the development and commercialization...
Antiverse collaborates with a top 20 pharma company to identify antibody drug candidates using...
Antiverse, a biotechnology company developing a computational antibody drug discovery platform, announced a partnership with...
Coriolis Pharma opens new ATMP formulation development facilities
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation...
Pfizer and BioNTech Initiate Rolling Submission for EUA of Their COVID-19 Vaccine in Children...
Pfizer Inc. and BioNTech SE announced that following a request from the U.S. FDA the...
Britain To Finally Vaccinate 5-11 Year Old’s Against COVID
Britain has already been slow to vaccinate its 5-11 year olds, and they are now...
Recipharm acquires GenIbet to bolster Biologics offering
Global contract development and manufacturing organisation (CDMO), Recipharm, has today announced the acquisition of GenIbet,...
